Phase II study of bevacizumab in combination with carboplatin plus paclitaxel as first-line chemotherapy for non-squamous non-small cell lung cancer with malignant pleural effusion

被引：0
|
作者：
Tamiya, M. [1 ]
Tamiya, A. [2 ]
Asami, K. [2 ]
Okishio, K. [3 ]
Kawagchi, T. [2 ]
Suzuki, H. [1 ]
Okamoto, N. [1 ]
Kawase, I. [1 ]
Atagi, S. [3 ]
Hirashima, T. [1 ]
机构：
[1] Osaka Prefectural Hosp Org, Osaka Prefectural Med Ctr, Habikino, Japan
[2] Kinki Chuo Chest Med Ctr, Sakai, Osaka, Japan
[3] Kinki Chuo Chest Med Ctr, Clin Res Ctr, Sakai, Osaka, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3492
引用
收藏
页码：S826 / S826
页数：1
相关论文
共 50 条
  • [21] A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients with advanced non-squamous non-small cell lung cancer
    Motohiro Tamiya
    Akihiro Tamiya
    Hiroyasu Kaneda
    Kazuhiko Nakagawa
    Kiyotaka Yoh
    Koichi Goto
    Hiroaki Okamoto
    Tsuneo Shimokawa
    Tetsuya Abe
    Hiroshi Tanaka
    Haruko Daga
    Koji Takeda
    Tomonori Hirashima
    Shinji Atagi
    Medical Oncology, 2016, 33
  • [22] Atezolizumab in combination with bevacizumab, paclitaxel and carboplatin for the first-line treatment of patients with metastatic non-squamous non-small cell lung cancer, including patients with EGFR mutations
    Reck, Martin
    Shankar, Geetha
    Lee, Anthony
    Coleman, Shelley
    McCleland, Mark
    Papadimitrakopoulou, Vassiliki A.
    Socinski, Mark A.
    Sandler, Alan
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2020, 14 (02) : 125 - 136
  • [23] Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer
    Niho, Seiji
    Kunitoh, Hideo
    Nokihara, Hiroshi
    Horai, Takeshi
    Ichinose, Yukito
    Hida, Toyoaki
    Yamamoto, Nobuyuki
    Kawahara, Masaaki
    Shinkai, Tetsu
    Nakagawa, Kazuhiko
    Matsui, Kaoru
    Negoro, Shunichi
    Yokoyama, Akira
    Kudoh, Shinzoh
    Kiura, Katsuyuki
    Mori, Kiyoshi
    Okamoto, Hiroaki
    Sakai, Hiroshi
    Takeda, Koji
    Yokota, Soichiro
    Saijo, Nagahiro
    Fukuoka, Masahiro
    LUNG CANCER, 2012, 76 (03) : 362 - 367
  • [24] Carboplatin plus Weekly Paclitaxel Combined with Bevacizumab as First-line Treatment for Non-small Cell Lung Cancer
    Yamasaki, Masahiro
    Murakami, Isao
    Nakano, Kikuo
    Doi, Mihoko
    Kitaguchi, Souichi
    Kondo, Tomohiro
    Sakurai, Joji
    Hattori, Noboru
    Arita, Ken-Ichi
    ANTICANCER RESEARCH, 2017, 37 (02) : 923 - 928
  • [25] COST EFFECTIVENESS OF BEVACIZUMAB ADDITION TO THE FIRST LINE OF CARBOPLATIN plus PACLITAXEL CHEMOTHERAPY IN PATIENTS WITH NON-SQUAMOUS NON-SMALL CELL LUNG CANCER WITH ECOG BETWEEN 0 AND 1
    Parody, E.
    Guevara, C. A.
    Aguirre, A. F.
    VALUE IN HEALTH, 2015, 18 (07) : A822 - A822
  • [26] A Phase Ii Study Of Carboplatin And Weekly Paclitaxel Combined With Bevacizumab For The First-Line Treatment Of Advanced Non-Small Cell Lung Cancer
    Kubota, T.
    Okano, Y.
    Sakai, M.
    Takaoka, M.
    Tsukuda, T.
    Anabuki, K.
    Kawase, S.
    Miyamoto, S.
    Ohnishi, H.
    Urata, T.
    Takeuchi, E.
    Ogushi, F.
    Yokoyama, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [27] Phase II Trial of Carboplatin, Pemetrexed, Bevacizumab in Advanced non-Small Cell (non-Squamous) Lung Cancer
    Guarino, Michael J.
    Masters, Gregory A.
    Biggs, David D.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S698 - S698
  • [28] A Phase II Study of First-Line Chemotherapy with Weekly Carboplatin Plus Gemcitabine in Advanced Non-Small Cell Lung Cancer
    Mori, Kiyoshi
    Kamiyama, Yukari
    Kasai, Hisashi
    Kodama, Tetsuro
    CHEMOTHERAPY, 2012, 58 (01) : 78 - 83
  • [29] Phase II study of bevacizumab in combination with cisplatin and docetaxel as first-line treatment of patients (p) with metastatic non-squamous non-small cell lung cancer (NSCLC)
    Ferrer, N.
    Cobo, M.
    Paredes, A.
    Mendez, M.
    Munoz-Langa, J.
    Rueda, A.
    de Mon, M. Alvarez
    Sanchez-Hernandez, A.
    Gallego, R.
    Torrego, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [30] Phase II study of carboplatin, docetaxel and bevacizumab for chemotherapy-naive patients with advanced non-squamous non-small cell lung cancer
    Takiguchi, Yuichi
    Iwasawa, Shunichiro
    Minato, Koichi
    Miura, Yosuke
    Gemma, Akihiko
    Noro, Rintaro
    Yoshimori, Kozo
    Shingyoji, Masato
    Hino, Mitsunori
    Ando, Masahiro
    Okamoto, Hiroaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (04) : 659 - 667
12345